Trace Element Concentrations in Autopsied Heart Tissues from Patients with Secondary Cardiomyopathy

Ana Ćirović1, Aleksandra Buha Đorđević2,3, Aleksandar Ćirović4

  • 1Faculty of Medicine, Institute of Anatomy, University of Belgrade, Dr Subotica 4/2, 11000, Belgrade, Serbia.

PubMed

Insights

Cardiomyopathy patients show higher levels of lead, nickel, manganese, and copper in heart tissue. Essential zinc levels were significantly lower in individuals with cardiomyopathy (CMP).

Area of Science:

  • Cardiology
  • Toxicology
  • Environmental Health

Background:

  • Cardiomyopathies (CMP) are a major cause of heart failure and transplantation, with poor long-term outcomes.
  • Heavy metals are known cardiotoxins, with elevated levels observed in blood and urine of heart disease patients.
  • Direct myocardial metal analysis in CMP has been lacking, particularly for essential metals like zinc (Zn).

Purpose of the Study:

  • To investigate and quantify metal concentrations in the left ventricle myocardium of individuals with CMP.
  • To compare metal profiles in CMP patients versus non-heart disease controls.

Main Methods:

  • Post-mortem left ventricle myocardial samples were collected from 52 individuals.
  • 19 samples were from diagnosed CMP patients (mean age 72 ± 10 years).
  • 33 samples were from individuals without heart disease (mean age 67 ± 15 years).
  • Metal concentrations (including lead, nickel, manganese, copper, and zinc) were analyzed.

Main Results:

  • CMP patients exhibited significantly higher concentrations of lead, nickel, manganese, and copper compared to controls (p ≤ 0.011).
  • Zinc levels were significantly lower in the myocardium of CMP subjects (p = 0.017).
  • These findings suggest an altered metal burden in the heart tissue of individuals with CMP.

Conclusions:

  • Increased myocardial concentrations of lead, nickel, manganese, and copper are associated with cardiomyopathy.
  • Reduced zinc levels in the heart may also play a role in CMP pathogenesis.
  • These results highlight the potential cardiotoxic effects of specific heavy metals and the importance of essential minerals in heart health.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
185
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
37
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
110